Researcher
Cédric Draulans
- Disciplines:Cancer therapy
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Aug 2016 → Today
Projects
1 - 1 of 1
- The Treasury of Images: exploring the opportunities for diagnosing and treating prostate cancerFrom1 Aug 2016 → 23 Nov 2020Funding: Private funding of national origin - undefined
Publications
1 - 10 of 23
- Risk Modeling for Individualization of the FLAME Focal Boost Approach in External Beam Radiation Therapy for Patients With Localized Prostate Cancer(2024)
Authors: Karin Haustermans, Cédric Draulans
Pages: 66 - 73 - From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trial(2023)
Authors: Lisa De Cock, Cédric Draulans, Sofie Isebaert, Karin Haustermans
- Genomic Classifiers in Personalized Prostate Cancer Radiation Therapy Approaches: A Systematic Review and Future Perspectives Based on International Consensus(2023)
Authors: Cédric Draulans, Gert De Meerleer, Karin Haustermans
Pages: 503 - 520 - Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer(2022)
Authors: Karin Haustermans, Cédric Draulans, Sofie Isebaert
Pages: 252 - 257 - Reply to Kamal Kant Sahu's Letter to the Editor re: Veerle H. Groen, Karin Haustermans, Floris J. Pos, et al. Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.012(2022)
Authors: Cédric Draulans, Karin Haustermans
Pages: E147 - E148 - Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial(2022)
Authors: Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt
Pages: 127 - 132 - Automated treatment planning of prostate stereotactic body radiotherapy with focal boosting on a fast-rotating O-ring linac: Plan quality comparison with C-arm linacs(2021)
Authors: Robin De Roover, Wouter Crijns, Cédric Draulans, Karin Haustermans, Tom Depuydt
- Anorectal dose-effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial(2021)
Authors: Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt
Pages: 98 - 104 - A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy(2021)
Authors: Cédric Draulans, Eric Van Cutsem, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans
Pages: 1121 - 1125 - Ga-68-PSMA-11 PET, F-18-PSMA-1007 PET, and MRI for Gross Tumor Volume Delineation in Primary Prostate Cancer: Intermodality and Intertracer Variability(2021)
Authors: Cédric Draulans, Raymond Oyen, Sofie Isebaert, Frederik Maes, Steven Joniau, Robin De Roover, Gilles Defraene, Karolien Goffin, Karin Haustermans
Pages: 202 - 211